10th Annual Report: Future Blockbusters
Potential blockbuster products in late-stage development include drugs for major adverse cardiac events, multiple sclerosis, rheumatoid arthritis, chronic obstructive pulmonary disease, hypercholesterolemia, and type 2 diabetes.
By Med Ad News Staff

To the point
Stepping up for Haiti
By Christiane Truelove

Sales managers left adrift
Corrective action is required as insufficient training and attention has left frontline managers ill equipped to lead the rapidly changing pharmaceutical sales force.
By Steven Niles

Partners in personalized medicine
As the idea of personalized medicine catches on within the healthcare industry, drug developers will need to forge strong partnerships with diagnostics companies.
By Joshua Slatko

CRM builds bonds in cardio
Ad agencies and their cardiovascular clients are becoming more conservative as this therapeutic segment enters an era of volatile change.
By Gina-Louise Monari



Sales & marketing
According to research by Cutting Edge Information, drug companies overwhelmingly agree that operating medical information call centers in house is more efficient.
By Joshua Slatko

Business
Novartis intends to gain full ownership of Alcon Inc. by first completing the April 2008 agreement with Nestlé SA to acquire a 77% majority stake in Alcon and subsequently entering into an all-share direct merger with Alcon for the remaining 23% minority stake.
By Steven Niles

The Leader's Edge: One thing at a time
Sander Flaum, managing partner, Flaum Partners, discusses why effective leaders must not only maintain a singular focus, but must project one as well.
By Sander Flaum

People on the Move
CSL Ltd. is instituting changes within its organizational structure and its senior executive group.
By Gina-Louise Monari

Ad Agency Update
Cadient Interactive’s newly launched Hatch Consulting services group is aligning strategic experts across a range of emerging areas of focus in healthcare marketing.
By Gina-Louise Monari

Pitch Therapy: Creative time zappers
Leave behinds, presentation themes, and creative reviews all have the potential to be major time zappers in the final days of developing a pitch, according to Mark Schnurman, pitch consultant and founder of Filament Inc.
By Mark Schnurman

Interactive & digital marketing
Offering a lesson in the rapid scalability of Internet applications, iGuard reached the milestone of two million users in December 2009.
By Joshua Slatko

FDA Focus
As part of its continuing effort to improve food and medical product safety in the United States by working with its regulatory partners overseas, FDA has opened a new post in Mexico City.
By Steven Niles

Drug Approvals
Eli Lilly and Co.'s Zyprexa Relprevv provides an additional treatment for patients to help maintain therapeutic drug levels.
By Gina-Louise Monari



Q&A with Jerry Acuff, CEO, Delta Point Inc.
In a conversation with Med Ad News, Delta Point CEO Jerry Acuff discusses the findings and ramifications of his company’s 2009 Leadership Skills Survey. As a consulting company that works mostly with pharmaceutical companies, Delta Point (gottochange.com) focuses on improving outcomes to help brands that are facing challenges, whether it is launching a new product, underperforming due to a noisy marketplace and/or facing stiff competition, or having difficulties in communicating the brand message.
By Steven Niles

Q&A with Robert Karczewski, Account Director, Partner, Reality Rx Communication
In a conversation with Med Ad News, Robert Karczewski of Reality Rx Communication discusses the opportunities and challenges in marketing the new generation of drug/diagnostic combination products, and how he sees the drug/diagnostic marketplace developing in the future.
By Joshua Slatko